Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
AerCap
AER
$23.7B
| $952K | ﹤0.01% |
14,544
-6,712
| -32% | -$415K |
|
2852
Mitek Systems
MITK
$754M
| $952K | ﹤0.01% |
53,588
+2,903
| +6% | +$51.9K |
|
|
SNP
2853
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $952K | ﹤0.01% |
20,466
-1,022
| -5% | -$49.4K |
|
2854
Johnson Outdoors
JOUT
$491M
| $951K | ﹤0.01% |
10,141
+4,475
| +79% | +$471K |
|
2855
Arcturus Therapeutics
ARCT
$164M
| $949K | ﹤0.01% |
25,623
+14,226
| +125% | +$580K |
|
2856
V2X
VVX
$2.83B
| $948K | ﹤0.01% |
20,739
+12,163
| +142% | +$577K |
|
2857
Myers Industries
MYE
$1.29B
| $944K | ﹤0.01% |
47,171
+18,298
| +63% | +$370K |
|
2858
IDEAYA Biosciences
IDYA
$3.42B
| $940K | ﹤0.01% |
39,760
+26,173
| +193% | +$608K |
|
2859
Business First Bancshares
BFST
$1.04B
| $936K | ﹤0.01% |
33,053
+25,166
| +319% | +$681K |
|
2860
Columbia Sportswear
COLM
$3.04B
| $934K | ﹤0.01% |
9,592
-7,905
| -45% | -$787K |
|
2861
TD Synnex
SNX
$20.4B
| $932K | ﹤0.01% |
8,151
-17,028
| -68% | -$1.85M |
|
|
VXRT
2862
DELISTED
Vaxart
VXRT
| $931K | ﹤0.01% |
148,557
+97,542
| +191% | +$666K |
|
|
NFBK
2863
DELISTED
Northfield Bancorp
NFBK
| $929K | ﹤0.01% |
57,440
+20,909
| +57% | +$361K |
|
2864
Ooma
OOMA
$598M
| $929K | ﹤0.01% |
45,460
+17,240
| +61% | +$351K |
|
2865
Grocery Outlet
GO
$909M
| $928K | ﹤0.01% |
32,758
-43,412
| -57% | -$1.11M |
|
2866
Allient
ALNT
$1.49B
| $923K | ﹤0.01% |
25,262
+9,376
| +59% | +$347K |
|
2867
SI-BONE Inc
SIBN
$788M
| $922K | ﹤0.01% |
41,488
+24,616
| +146% | +$530K |
|
|
SRDX
2868
DELISTED
Surmodics
SRDX
| $922K | ﹤0.01% |
19,159
+5,481
| +40% | +$276K |
|
|
SLCA
2869
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $922K | ﹤0.01% |
98,132
-29,831
| -23% | -$297K |
|
2870
PUT
Green Plains
GPRE
$1.18B
| $921K | ﹤0.01% |
26,500
-180,000
| -87% | -$6.69M |
|
2871
Quad
QUAD
$536M
| $921K | ﹤0.01% |
230,329
-340,103
| -60% | -$1.39M |
|
2872
Scholar Rock
SRRK
$5.67B
| $919K | ﹤0.01% |
37,034
+21,712
| +142% | +$599K |
|
|
CLR
2873
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $918K | ﹤0.01% |
20,500
-14,800
| -42% | -$704K |
|
2874
Crawford & Co Class A
CRD.A
$532M
| $916K | ﹤0.01% |
122,344
+12,966
| +12% | +$107K |
|
2875
Civista Bancshares
CIVB
$604M
| $906K | ﹤0.01% |
37,107
+11,953
| +48% | +$294K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.